Volume 5, Issue 2 (6-2013)                   IJDO 2013, 5(2): 77-82 | Back to browse issues page

XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Ahadian H, Hajimaghsoodi S, Afkhami-Ardekani M. Prevalence of Anti Hyperglycemic Agents -Associated Oral Lichenoid Lesions in Type 2 Diabetes Mellitus Patients. IJDO 2013; 5 (2) :77-82
URL: http://ijdo.ssu.ac.ir/article-1-137-en.html
Department of Oral Medicine, Shahid Sadoughi University of Medical Science, Yazd, Iran
Abstract:   (4927 Views)
Objective: This study aimed to estimate the prevalence of lichenoid reactions to Anti Hyperglycemic Agents. Materials and Methods: In this cross-sectional descriptive and analytic study, we examined the oral mucosa of 411 patients at the age of 29 to 85 in 3 groups who consumed various antihyperglycemic agents. Results: In overall, 31 patients had lichenoid reactions (12 patients taking glibenclamide, 1 patient taking metformin and 18 patients taking glibenclamide with metformin) and there was a significant difference between the groups (P = 0.013). The most of the lesions were at the age's upper than 60 years. From 31 patients with lichenoid reactions, 14 subjects (45%) were male and 17 subjects (55%) were female. Conclusion: Prevalence of lichenoid reactions in this study was 7.5% approximately. By considering the significant difference among the groups in the incidence of lesions, the significant effect of glibenclamide in inducing lichenoid reactions can be considared.
Full-Text [PDF 107 kb]   (3218 Downloads)    
Type of Study: Research | Subject: Special
Received: 2014/03/15 | Accepted: 2014/03/15 | Published: 2014/03/15

Add your comments about this article : Your username or Email:
CAPTCHA

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2024 CC BY-NC 4.0 | Iranian Journal of Diabetes and Obesity

Designed & Developed by : Yektaweb